Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Corbus Pharmaceuticals Holdings (CRBP) Return on Sales (2016 - 2022)

Corbus Pharmaceuticals Holdings has reported Return on Sales over the past 8 years, most recently at 4.6% for Q2 2022.

  • For Q2 2022, Return on Sales fell 337.0% year-over-year to 4.6%; the TTM value through Jun 2022 reached 4.6%, down 436.0%, while the annual FY2021 figure was 0.64%, 39.0% down from the prior year.
  • Return on Sales for Q2 2022 was 4.6% at Corbus Pharmaceuticals Holdings, down from 2.1% in the prior quarter.
  • Over five years, Return on Sales peaked at 0.01% in Q4 2019 and troughed at 4.6% in Q2 2022.
  • A 5-year average of 0.76% and a median of 0.2% in 2021 define the central range for Return on Sales.
  • Biggest five-year swings in Return on Sales: surged 87bps in 2019 and later plummeted -337bps in 2022.
  • Year by year, Return on Sales stood at 0.86% in 2018, then surged by 101bps to 0.01% in 2019, then tumbled by -1378bps to 0.12% in 2020, then crashed by -425bps to 0.64% in 2021, then crashed by -624bps to 4.6% in 2022.
  • Business Quant data shows Return on Sales for CRBP at 4.6% in Q2 2022, 2.1% in Q1 2022, and 0.64% in Q4 2021.